Shortness of Breath in a Swimming Athlete by Spinelli, A. & Getzin, A.
 
Mid Atlantic Regional Chapter 
of the 
American College of Sports Medicine 
 
Annual Scientific Meeting, November 2nd - 3rd, 2018 
Conference Proceedings 
International Journal of Exercise Science, Issue 9, Volume 7 
12-648  LC    WHITE
Shortness of Breath in a Swimming Athlete 
 
Anthony Spinelli, MS, ATC, CSCS; Cayuga Medical Center, Ithaca NY 
aspinelli@cayugamed.org (Sponsor: Andrew Getzin, MD) 
 
HISTORY: 13yr old female with shortness of breath during exercise. Symptoms presented in the winter of 2017/18. 
She is regular qualifier for the NYSPHAA State Championships. Her symptoms are described as “tightness in my 
throat and chest” while swimming longer distances and repeated bouts of sprinting. She describes more trouble with 
inspiration than expiration.  
 
DIFFERENTIAL DIAGNOSIS: 1) Baseline asthma 2) Exercise-Induced Asthma 3) Exercise –Induced Laryngeal 
Obstruction 4) Unreasonable fitness expectations  5)Anemia 6) Cardiac pathology 7) Lung pathology 
 
PHYSICAL EXAMINATION: Healthy and well developed 13yr old 
Ht: 62.5" Wt: 105lb BMI: 19.3  
 
TESTS AND RESULTS:   
03/01/17: Spirometry; WNL, no significant response to beta agonist 
 
03/01/17: ECG: Sinus arrhythmia otherwise WNL, Resting HR: 62bpm 
Hemoglobin/ Hematocrit: 14mg/dL and 42% 
03/01/17: CXR, PA and lateral: WNL 
 
04/06/17: Exercise Induced Asthma provocation test  
Peak VO2: 57.6ml/kg/min 
Post exercise decrease in FEV1 of 26%  
Obstructive expiratory loop that improved with Albuterol  
 
8/17/17: Continuous Laryngoscopy with Exercise 
Grade 2 supraglottic closure with posterior movement of the epiglottis causing closure of the upper airway at sub max 
workload 
 
FINAL/WORKING DIAGNOSIS:  Comorbidity of grade 2 supraglottic (EILO) and mild (EIA) 
 
TREATMENT AND OUTCOMES: Successful evidence was gathered to diagnose patient with EILO and EIA 
Conservative treatment of 6 weeks speech therapy was initiated which includes poolside therapy 
 
Medication was prescribed for EIA 
•   Qvar 40 mcg/Act 2 puffs twice a day  
•   Proair HFA  108 (90 Base) mcg/Act  2 puffs as needed at the onset of shortness of breath and prior to exercise  
 
The patient is still competing at a high level and continuing to improve times in swimming events. It has been a 
multifaceted approach including medication, speech therapy, and further education about the comorbidity of EIA and 
EILO. Timing of her rescue inhaler is crucial to not exacerbate EILO symptoms. Performing speech therapy poolside 
has been a unique challenge. The patient will continue to follow up regularly for repeat spirometry, monitoring of 
medication usage, and update on symptoms.  
 
